252 related articles for article (PubMed ID: 2522911)
1. Lymphokine-activated killer-cell function of lymphocytes from peripheral blood, regional lymph nodes and tumor tissues of patients with oral cancer.
Tatake RJ; Krishnan N; Rao RS; Fakih AR; Gangal SG
Int J Cancer; 1989 Apr; 43(4):560-6. PubMed ID: 2522911
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactivity of lymphocytes from draining lymph nodes, peripheral blood and tumor infiltrates from oral cancer patients.
Mukhopadhyaya R; Tatake RJ; Krishnan N; Rao RS; Fakih AR; Naik SL; Gangal SG
J Clin Lab Immunol; 1989 Sep; 30(1):21-5. PubMed ID: 2641790
[TBL] [Abstract][Full Text] [Related]
3. The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer.
Letessier EM; Sacchi M; Johnson JT; Herberman RB; Whiteside TL
Cell Immunol; 1990 Oct; 130(2):446-58. PubMed ID: 2145080
[TBL] [Abstract][Full Text] [Related]
4. Natural killer and lymphokine-activated killer cell-mediated cytotoxicity in patients with oral cancer.
Gangal SG; Tatake RJ; Krishnan N; Mukhopadhyaya R; Naik SL; Fakih AR; Rao RS
Semin Surg Oncol; 1989; 5(5):347-50. PubMed ID: 2814145
[TBL] [Abstract][Full Text] [Related]
5. Induction of lymphokine-activated killer activities in peripheral blood lymphocytes and regional lymph node lymphocytes against PC-9 cultured adenocarcinoma and autologous pulmonary adenocarcinoma cells.
Morikawa Y; Watanabe S; Kodama T
Jpn J Clin Oncol; 1987 Jun; 17(2):129-39. PubMed ID: 3497285
[TBL] [Abstract][Full Text] [Related]
6. Different immune functions of peripheral blood, regional lymph node, and tumor infiltrating lymphocytes in lung cancer patients.
Nakamura H; Ishiguro K; Mori T
Cancer; 1988 Dec; 62(12):2489-97. PubMed ID: 3142676
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-2 mediated regulation of mitogen-activated T cell reactivity from different lymphoid sources in patients with squamous cell carcinoma of the oral cavity.
Murali PS; Somasundaram R; Rao RS; Fakih AR; Gangal SG
J Oral Pathol Med; 1989 Jul; 18(6):327-32. PubMed ID: 2810131
[TBL] [Abstract][Full Text] [Related]
8. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
[TBL] [Abstract][Full Text] [Related]
9. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.
Grimm EA; Ramsey KM; Mazumder A; Wilson DJ; Djeu JY; Rosenberg SA
J Exp Med; 1983 Mar; 157(3):884-97. PubMed ID: 6601174
[TBL] [Abstract][Full Text] [Related]
10. Effect of anti-CD3 antibody on the generation of interleukin-2-activated lymphocytes from tumor tissues of gastrointestinal cancer.
Ohta T; Kikuchi H; Ogata H; Iwata K; Yoshida K; Katayama K; Watanabe H
Cancer; 1992 Aug; 70(4):741-8. PubMed ID: 1386555
[TBL] [Abstract][Full Text] [Related]
11. Functional and phenotypic analysis of lymphocytes in head and neck cancer.
Snyderman CH; Heo DS; Johnson JT; D'Amico F; Barnes L; Whiteside TL
Arch Otolaryngol Head Neck Surg; 1991 Aug; 117(8):899-905. PubMed ID: 1832546
[TBL] [Abstract][Full Text] [Related]
12. Generation and expansion of lymphokine-activated killer cells from lymph node lymphocytes in human lung cancer.
Yano T; Yasumoto K; Nomoto K
Eur J Cancer Clin Oncol; 1989 Feb; 25(2):201-8. PubMed ID: 2784761
[TBL] [Abstract][Full Text] [Related]
13. Distinct cytotoxicity against neuroblastoma cells of peripheral blood and tumor-infiltrating lymphocytes from patients with neuroblastoma.
Kataoka Y; Matsumura T; Yamamoto S; Sugimoto T; Sawada T
Cancer Lett; 1993 Sep; 73(1):11-21. PubMed ID: 8402593
[TBL] [Abstract][Full Text] [Related]
14. Characterization of lymphokine-activated killer cells from peripheral blood and lymph nodes of non-Hodgkin's lymphoma patients.
Nadkarni JJ; Jhaver KG; De AK; Soman CS; Nadkarni KS
Neoplasma; 1993; 40(1):15-20. PubMed ID: 8350943
[TBL] [Abstract][Full Text] [Related]
15. Functional character and augmentation of lymphocytes in regional lymph nodes of patients with lung cancer.
Watanabe Y; Hashizume Y; Shimizu J; Yoshida M; Watanabe S; Iwa T; Sakai S; Migita S; Sato H; Murayama T
Am Rev Respir Dis; 1990 Oct; 142(4):769-74. PubMed ID: 2221581
[TBL] [Abstract][Full Text] [Related]
16. Identification and selection of human lymphokine activated killer cell effectors and novel recycling intermediates by unique light-scattering properties.
Loudon WG; Abraham SR; Owen-Schaub LB; Hemingway LL; Hemstreet GP; DeBault LE
Cancer Res; 1988 Apr; 48(8):2184-92. PubMed ID: 3258186
[TBL] [Abstract][Full Text] [Related]
17. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic characterization of lymphokine-activated killer cells from human lymph node lymphocytes.
Yano T; Murata M; Ishida T; Mitsudomi T; Kimura G; Sugimachi K; Nomoto K
Cell Immunol; 1989 Sep; 122(2):578-84. PubMed ID: 2788522
[TBL] [Abstract][Full Text] [Related]
19. Effects of systemic recombinant interleukin-2 on natural killer and lymphokine activated killer activity of human tumor infiltrating lymphocytes.
Anderson TM; Ibayashi Y; Tokuda Y; Colquhoun SD; Holmes EC; Golub SH
Cancer Res; 1988 Mar; 48(5):1180-3. PubMed ID: 3257716
[TBL] [Abstract][Full Text] [Related]
20. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
